Please read and agree to the
terms and conditions
of this site.
I agree
Medical Technology
/tech
Clear filters and search
Format
photo
Tags
biotech
clinical trials
3
×
fda
life sciences
national blog main
national top stories
roche
3
×
boston
boston blog main
boston top stories
deals
genentech
san francisco top stories
alexion pharmaceuticals
alnylam pharmaceuticals
avapritinib
billy dunn
biogen
blueprint medicines
boehringer ingelheim
cstone pharmaceuticals
dicerna pharamceuticals
drug prices
drug pricing
eli lilly
europe top stories
european medicines agency
evrysdi
fisogatinib
flatiron health
gene therapy
hepatitis b
hepatitis b virus
hepatocellular carcinoma
hereditary transthyretin amyloidosis
investing
ionis pharmaceuticals
jeff albers
medullary thyroid cancer
national
What
drug
roche
3
×
fda
intended
medicines
team
approval
approved
atrophy
blueprint
cancer
candidate
caught
causing
currently
daily
dicerna
disease
evrysdi
eye
friday
gene
green
hepatitis
home
lights
liquid
marketing
medicine
muscle
muscular
new
oral
pact
patients
pay
pharma
pharmaceuticals
producing
protein
Language
unset
Current search:
roche
×
roche
×
" clinical trials "
×
@xconomy.com
3 years ago
FDA Green-Lights Roche Spinal Muscular Atrophy Drug, First Oral Therapy
@xconomy.com
3 years ago
Roche, Blueprint Medicines Team Up Again in $775M RET Cancer Drug Pact
@xconomy.com
4 years ago
Roche to Pay Dicerna Pharma $200M to Team Up on Hepatitis B Drug